At the 61st annual European Association for the Study of Diabetes Conference (EASD) this week in Vienna, Austria, glucose monitoring company Dexcom introduced its new offering, the Dexcom Smart Basal, ...
Diabetes, affecting millions worldwide, poses a significant challenge to the healthcare system due to the complexity of therapy and difficulty to adequately control the disease. Particularly, patients ...
A custom artificial intelligence (AI) app for insulin management advice helped patients with type 2 diabetes gain rapid glycemic control, a small randomized clinical trial found. In titrating basal ...
A patient-facing voice-based conversational artificial intelligence (VBAI) application that provided autonomous basal insulin titration improved time to optimal insulin dosing, insulin adherence, and ...
Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers. * Dexcom Smart Basal is FDA cleared and now the ...
Please provide your email address to receive an email when new articles are posted on . Adults with type 2 diabetes reached their optimal basal insulin dose in 15 days with use of an artificial ...
Dexcom has won FDA clearance of the Smart Basal, a CGM-integrated basal insulin dosing optimizer designed for adults with Type 2 diabetes on glargine U-100 long-acting insulin therapy. The clearance ...
Diabetes is a condition that interferes with blood sugar levels in people whose bodies don't produce the right amount of insulin — a hormone made in the pancreas. Blood sugar that’s too high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results